MIT has launched the Rare Brain Disorders Nexus (RareNet) to enhance research on rare brain conditions, founded with a philanthropic donation from Ana Méndez and Rajeev Jayavant.

MIT engineers developed a new system for precise synthetic gene expression control, promising advancements in gene therapy and cellular function consistency.

MIT proposes a hybrid ammonia production method that could cut emissions by 63% by combining 'blue' and 'green' techniques, utilizing waste products more efficiently.

MIT and Harvard researchers have created a new type of immune cell, CAR-NK cells, to effectively target and kill cancer cells with reduced risk of immune rejection.

MIT chemists have developed a red fluorescent dye with borenium ions for better biomedical imaging. The dye is stable and has a high quantum yield, potentially useful in medical diagnostics, temperature sensing, and creating OLEDs.

Researchers at MIT CSAIL and McMaster University created enterololin, a compound selective against harmful gut bacteria while sparing the microbiome, developed using a generative AI model.

MIT researchers developed a model that could enhance the charging speed and lifespan of lithium-ion batteries by focusing on the reaction rate of lithium ions and electron transfer.

MIT researchers have developed a new framework for designing complex systems that incorporates uncertainty, potentially revolutionizing the engineering process for robust and sophisticated technologies.

MIT researchers discovered that a diet high in cysteine can accelerate the regeneration of the small intestine's lining, a finding with potential benefits for patients undergoing cancer treatments.

MIT joined the consortium building the Giant Magellan Telescope in Chile, with a significant donation from Phillip and Susan Ragon enhancing U.S. leadership in astronomy.

MIT scientists explore how the brain seamlessly processes visual information from both eyes without a perceptible seam, suggesting a synchronized handoff between hemispheres for smooth perception.

An MIT study found that over half of FDA-approved drugs since 2000 have connections to NIH research, highlighting the potential impact of proposed NIH budget cuts on future drug development.

MIT research reveals that intestinal mucus, particularly MUC2, contains molecules that can deactivate Salmonella infection pathways, which may lead to preventive treatments against gastrointestinal pathogens.